Citius Pharmaceuticals, Inc. Annual Return On Equity in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Citius Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2020 to 2023.
  • Citius Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was -44.7 %, a 44% decline year-over-year.
  • Citius Pharmaceuticals, Inc. annual Return On Equity for 2023 was -34 %, a 15.4% decline from 2022.
  • Citius Pharmaceuticals, Inc. annual Return On Equity for 2022 was -29.5 %, a 34.7% decline from 2021.
  • Citius Pharmaceuticals, Inc. annual Return On Equity for 2021 was -21.9 %, a 65.5% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -34 -4.55 -15.4% Oct 1, 2022 Sep 30, 2023
2022 -29.5 -7.6 -34.7% Oct 1, 2021 Sep 30, 2022
2021 -21.9 +41.5 +65.5% Oct 1, 2020 Sep 30, 2021
2020 -63.4 Oct 1, 2019 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.